Natsumi Hayashi

Antitumor effects of novel mAbs against cationic amino acid transporter 1 (CAT1) on human CRC with amplified CAT1 gene

S. Okazaki, T. Masuko, Y. Endo, 2020, Cancer science.

Novel functional anti-HER3 monoclonal antibodies with potent anti-cancer effects on various human epithelial cancers

S. Okazaki, T. Masuko, M. Inoue, 2020, Oncotarget.

Anticancer agent synthesis designed by artificial intelligence: Pd(OAc)2-catalyzed one-pot preparation of biphenyls and its application to a concise synthesis of various diazofluorenes

T. Masuko, T. Takabatake, M. Toyota, 2020 .

Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target

S. Okazaki, T. Masuko, Y. Endo, 2021, Oncotarget.

Anti‐tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS‐mutated human colorectal cancer cells

T. Masuko, K. Masuko, Yuta Hara, 2019, Cancer medicine.